Ondansetron in multiple sclerosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11068160.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron. Palliative care is a neglected aspect of management of degenerative neurological diseases and these cases highlight the approaches that may be used to manage difficult symptoms in the population with multiple sclerosis.
Medical subject headings
- Multiple Sclerosis
- Nausea
- Ondansetron
- Serotonin Antagonists
- Vertigo